Comparative Effectiveness of Oxaliplatin vs. 5-flourouricil in Older Adults: An Instrumental Variable Analysis

BACKGROUND: Oxaliplatin was rapidly adopted for treatment of stage III colon cancer after FDA approval in November 2004, thus providing an opportunity to use calendar time as an instrumental variable (IV) in nonexperimental comparative effectiveness research. Assuming instrument validity, IV analyse...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Epidemiology
Päätekijät: Mack, Christina DeFilippo, Brookhart, M. Alan, Glynn, Robert J., Meyer, Anne Marie, Carpenter, William R., Sandler, Robert S., Stürmer, Til
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2015
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4906444/
https://ncbi.nlm.nih.gov/pubmed/26196683
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/EDE.0000000000000355
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia